Key Decisions in HIV Care: Rapid Initiation of ART

In this episode from the series “Key Decisions in HIV Care,” Jason Halperin, MD, MPH, and Jürgen K. Rockstroh, MD, discuss important considerations in the rapid initiation of ART, including guideline recommendations and data supporting recommended ART regimen options for rapid initiation and emerging data for the 2-drug regimen dolutegravir/lamivudine for rapid start from the STAT study. Following their dialogue, the faculty field questions from healthcare professionals. Presenters: Jason Halperin, MD, MPH Assistant Professor of Medicine Department of Infectious Diseases Tulane University Infectious Disease Physician CrescentCare New Orleans, Louisiana Jürgen K. Rockstroh, MD Professor of Medicine University Hospital Bonn Department of Medicine I Bonn, Germany  Content based on an online CME program supported by educational grants from Gilead Sciences, Inc.; Janssen Therapeutics, Division of Janssen Products, LP; and ViiV Healthcare. Follow along with the slides at:  https://bit.ly/2XWPuBi Link to full program:  https://bit.ly/2TXTYWx Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.